- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06307145
Korea Hip Replacement Surgery Registry
March 5, 2024 updated by: Juhee Cho, Samsung Medical Center
Efficacy and Safety of Hip Replacement Surgery Using Korean National Registry
This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database.
For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019.
Using this registry, we compared efficacy and safety by type of head or liner.
Study Overview
Status
Completed
Conditions
Detailed Description
This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database.
For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019.
Using this registry, we compared efficacy and safety by type of head or liner.
The safety issues included the incidence of cancer, orthoperiodic outcome (dislocation, mechanical Cx, periprosthetic join infection, periprosthetic fracture), revision, embolism or thrombosis, cardiac outcome, and death
Study Type
Observational
Enrollment (Actual)
124556
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patient aged 19 or older who received hip replacement surgery
Description
Inclusion Criteria:
- Patient aged 19 or older who received hip replacement surgery
Exclusion Criteria:
- Insufficient information
- history of any revision
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cancer
Time Frame: the occurrence of cancer, death, or December 31st, 2019 (end of the study), whichever came first.
|
Incidence of cancer
|
the occurrence of cancer, death, or December 31st, 2019 (end of the study), whichever came first.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Juhee Cho, Samsung Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2003
Primary Completion (Actual)
December 31, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
March 5, 2024
First Submitted That Met QC Criteria
March 5, 2024
First Posted (Actual)
March 12, 2024
Study Record Updates
Last Update Posted (Actual)
March 12, 2024
Last Update Submitted That Met QC Criteria
March 5, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- K-NHIS-HIP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Access to the dataset is limited to researchers who have been approved by the NHIS.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Replacement Surgery
-
Basilea PharmaceuticaCompletedTotal Hip Replacement Surgery
-
Peking University First HospitalBeijing HospitalNot yet recruitingSleep Quality | Dexmedetomidine | Old Age | Knee Replacement Surgery | Hip Replacement SurgeryChina
-
Peking University First HospitalBeijing HospitalRecruitingSleep Quality | Dexmedetomidine | Old Age | Esketamine | Knee Replacement Surgery | Hip Replacement SurgeryChina
-
Mayo ClinicWithdrawnTotal Hip Replacement Surgery | Total Knee Replacement SurgeryUnited States
-
Northwell HealthWithdrawnOrthopaedic Surgery | Total Hip Arthroplasty | Hip Replacement | Hip ImplantUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedOrthopedic Surgery | Total Knee Replacement | Total Hip ProsthesisFrance
-
Ospedale Edoardo BassiniNot yet recruitingRegional Anesthesia | Regional Anesthesia Block | Total Hip Replacement Surgery | Total Hip Arthroplasty \(THA\)
-
CHU de ReimsUnknownTotal Hip Replacement SurgeryFrance
-
Baxter Healthcare CorporationCompletedHip Replacement SurgeryAustria, Germany, Netherlands
-
The Royal Bournemouth HospitalCompletedArthroplasty, Replacement, Hip | Hip Replacement, TotalUnited Kingdom